Raymond James Reiterates Outperform on CME Group, Maintains $320 Price Target
CME Group Inc. Class A
CME Group Inc. Class A CME | 0.00 |
Raymond James analyst Patrick O'Shaughnessy reiterates CME Group (NASDAQ:
CME) with a Outperform and maintains $320 price target.
